covid

Oncology and a year of COVID: lessons for the future

https://deep-dive.pharmaphorum.com/magazine/oncology-2021/oncology-and-a-year-of-covid-lessons-for-the-future/

How hybrid virtual engagement is accelerating oncology communication

https://deep-dive.pharmaphorum.com/magazine/oncology-2021/how-hybrid-virtual-engagement-is-accelerating-oncology-communication/

Why pharma shouldn’t forget about sites in a post-COVID world

https://deep-dive.pharmaphorum.com/magazine/oncology-2021/why-pharma-shouldnt-forget-about-sites-in-a-post-covid-world/

Keeping clinical trial data safe – handling cybersecurity in a risky world

https://pharmaphorum.com/views-and-analysis/keeping-clinical-trial-data-safe-handling-cybersecurity-in-a-risky-world/

Inside the UK’s leading efforts to restart clinical research

https://deep-dive.pharmaphorum.com/magazine/research-and-development-2021/inside-uks-leading-efforts-restart-clinical-research/

Pfizer files tick-borne encephalitis shot with FDA

https://pharmaphorum.com/news/pfizer-files-tick-borne-encephalitis-shot-with-fda/

Digital therapeutics: Why human psychology is key to adoption

https://deep-dive.pharmaphorum.com/magazine/digital-health-innovation-2020/digital-therapeutics-why-human-psychology-is-key-to-adoption/

The right people and the right environment for innovative comms

https://deep-dive.pharmaphorum.com/magazine/communications-2020/the-right-people-and-the-right-environment-for-innovative-comms/

People with Chronic Conditions Concerned About “Returning to Normal” During Pandemic

https://pharmaphorum.com/partner-content/people-with-chronic-conditions-concerned-about-returning-to-normal-during-pandemic/

1 2

Close in 10 seconds

Pharmaphorum.com

Search